ArticleRadiation oncology journal2017

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma.

Katsuyuki Sakanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.